The changes of serum intact fibroblast growth factor 23 in type 2 diabetes patients with different phases of diabetic nephropathy

Bao-yu ZHANG,Qian-qian PANG,Yan JIANG,Ou WANG,Mei LI,Xiang-ping XING,Dong ZHAO,Wei-bo XIA
DOI: https://doi.org/10.3969/j.issn.1674-2591.2015.02.005
2015-01-01
Abstract:Objective To investigate the changes of serum intact fibroblast growth factor 23 ( iFGF-23) levels in type 2 diabetes ( T2DM) patients with diabetic nephropathy in different stages, and analysis the correlation of the lev-els of serum iFGF-23 with the levels urinary albumin excretion rate ( UAER) and renal functions.Methods A total of 119 patients with type 2 diabetes and 29 healthy control subjects were enrolled.According to urinary albumin excretion rate and renal function, the patients with type 2 diabetes were divided into four groups:urinary albumin excretion rate in normal group ( group DM1, 8°UAER <20 μg/min, serum creatinine was normal, n=30 ) , microalbuminuria group (group DM2, 8°UAER 20~200 μg/min, serum creatinine level is normal, n=30), clinical albuminuria group (group&nbsp;DM3, 8°UAER>200 μg/min, serum creatinine level is normal, n=28) , uremic hemodialysis group ( DM4 group, n=31), normal control group (group N, n=29).The general data of the subjects was recorded.Fasting venous blood sam-ples were collected for glucose, lipid, liver and kidney function, intact parathyroid hormone ( iPTH) , and serum iFGF-23 determination.8 hour urine (from 10pm to 6am) was also collected for UAER detection.Results Serum iFGF-23 of 558.93 (168.65-2 333.5) pg/mL levels in DM4 group was significantly increased than other groups (P<0.001), but no significant difference among the other groups.The levels of serum iFGF-23 negatively correlated with estimated glomer-ular filtration rate ( eGFR) , but positively correlated with serum creatinine ( Scr) , blood urea nitrogen ( BUN) , glucose ( GLU) , serum phosphorus ( P) and iPTH.Conclusion The levels of iFGF-23 increased significantly in the late stage of diabetic nephropathy.The levels of iFGF-23 were positively correlated with the levels of creatinine, blood urea nitro-gen, phosphorus and iPTH, and were negatively correlated with eGFR.This study suggested that the levels of serum iFGF-23 can not be used as a new biomarkers for negatively early diagnosis of diabetic nephropathy.
What problem does this paper attempt to address?